Market Cap

Evgen Pharma plc Market Capitalization:

£865,377

GBP as of Jan. 1, 2026

US$1.2 Million

business Evgen Pharma plc Company Profile

Evgen Pharma plc Main Stock Listing

LSE: EVG

Market Capitalization History of Evgen Pharma plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Evgen Pharma plc market cap

Date Market Cap YoY Change
Jan. 1, 2026 £865,377 -74.69%
Jan. 1, 2025 £3.4 M -48.39%
Jan. 1, 2024 £6.6 M -64.16%
Jan. 1, 2023 £18.5 M -5.98%
Jan. 1, 2022 £19.7 M -50.34%
Jan. 1, 2021 £39.6 M 103.25%
Jan. 1, 2020 £19.5 M -71.06%
Jan. 1, 2019 £67.3 M 11.70%
Jan. 1, 2018 £60.3 M -31.22%
Jan. 1, 2017 £87.6 M -5.75%
Jan. 1, 2016 £92.9 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Evgen Pharma plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

Evgen Pharma plc has the following listings and related stock indices.


Stock: LSE: EVG

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.